Clinical Research News
-
CStone to initiate clinical development of CS1001 and BLU-554 in combination therapy for HCC
Clinical Research | News | 0 Comment | 06 Jun, 2019
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in China of CS1001 in combination with BLU-554 (CS3008) in patients ...Read more
-
Genentech announces meeting of primary endpoint of Ph III study
Clinical Research | News | 0 Comment | 04 Jun, 2019
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi & Co. Ltd. met its primary endpoint showing that people exposed to a...Read more
-
Saluda Medical announces clinical study results of the chronic pain treatment
Clinical Research | News | 0 Comment | 03 Jun, 2019
Saluda Medical Pty Limited ("Saluda Medical") has announced data from two clinical studies evaluating the performance of the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Co...Read more
-
Innovent announces preliminary results of Sintilimab at ASCO
Clinical Research | News | 0 Comment | 31 May, 2019
Innovent Biologics, a world-class biopharmaceutical company that develops and commercializes high quality medicines has announced that the preliminary results of sintilimab, the anti-P...Read more
-
Pi Therapeutics announces $19.7 M Series B Financing
Clinical Research | News | 0 Comment | 30 May, 2019
Pi Therapeutics, a company dedicated to the development of novel modulators of protein degradation for cancer has announced the completion of a $19.7 million Series B financing. T...Read more
-
Up to six new HBV drugs set to launch by 2027, with China driving market growth, says GlobalData
Clinical Research | News | 0 Comment | 29 May, 2019
Within the next ten years, up to six new drugs are projected to be approved for the treatment of chronic hepatitis B virus (HBV) infections in the eight major markets (8MM*), according...Read more
-
Agios's Phase 3 ClarlDHy trial of TIBSOVO meet its primary endpoint
Clinical Research | News | 0 Comment | 28 May, 2019
The partner of CStone Pharmaceuticals, Agios Pharmaceuticals has announced that the global Phase 3 ClarIDHy trial of TIBSOVO (ivosidenib) in previously treated cholangiocarcinoma patie...Read more
-
Takeda announces results of Phase 3b VARSITY studies
Clinical Research | News | 0 Comment | 20 May, 2019
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, which demonstrated that the gut-selective biologic vedolizumab (Entyvi...Read more
-
Study demonstrates Clinical Utility of Liquid Biopsy for Cancer Monitoring
Clinical Research | News | 0 Comment | 17 May, 2019
Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with cancer. A new retrospective clinical research study showing comparab...Read more
-
Clinical Research | News | 0 Comment | 15 May, 2019
Ping An Insurance Company of China has announced that its technology arm, Ping An Technology, has completed a prospective multi-centre clinical trial for the world's fi...Read more
-
Promethera Biosciences makes progress in HepaStem development programme
Clinical Research | News | 0 Comment | 09 May, 2019
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a first patient in a Phase 2a clinical study for the company’s He...Read more
-
WISE enrolls first patient in pivotal clinical study of novel neuro-electrodes for brain monitoring
Clinical Research | News | 0 Comment | 08 May, 2019
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring and neuromodulation, has enrolled its first patient in the pivotal clinical study of its ...Read more
-
AstraZeneca’s Calquence phase III ASCEND trial meets positive result
Clinical Research | News | 0 Comment | 08 May, 2019
AstraZeneca announced positive results from the phase III ASCEND trial of Calquence (acalabrutinib) in previously-treated patients with chronic lymphocytic leukaemia (CLL). Results showed a...Read more
-
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response
Clinical Research | News | 0 Comment | 08 May, 2019
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal phase 2 DESTINY-Breast01 trial of [fam-] trastuzumab deruxtecan (DS-...Read more
-
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints
Clinical Research | News | 0 Comment | 08 May, 2019
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse chimeric anti-cell surface protein (anti-CD20) monoclonal antibody b...Read more
-
VolitionRx initiates clinical trial programme in lung cancer
Clinical Research | News | 0 Comment | 08 May, 2019
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution of a contract under the previously announced Memorandum of Understan...Read more
-
Clinical research is becoming more disintegrated with the influx of data from different sources
Clinical Research | Opinion | 0 Comment | 07 May, 2019
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical market, dynamic healthcare landscape and access to patient pools. To ...Read more
-
Clinical Research | News | 0 Comment | 03 May, 2019
Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide range of cancers, has announced 'proof-of-concept' data from the preclini...Read more
